<DOC>
	<DOCNO>NCT01717105</DOCNO>
	<brief_summary>The present study design order characterize incidence patient advance non-small cell lung cancer ( NSCLC ) carry epidermal growth factor receptor ( EGFR ) positive mutation clinical management Galicia .</brief_summary>
	<brief_title>Observational Study Characterize Incidence EGFR Mutation Positive Advanced NSCLC Patients</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>Inclusion Criteria patients´ screening : Patients sex age 18 . Histologically confirm advanced metastatic NonSmallCell Lung Cancer ( NSCLC ) ( patient stage III B unsuitable locoregional treatment , stage IV ) . Chemo naïve patient ( NonSmallCell Lung Cancer patient receive first line systemic cytotoxic chemotherapy ) . Patients available tumoral tissue ( primary tumor metastatic area ) cytological sample include fine needle aspirate ( primary tumor metastatic area ) , bronchial alveolar lavage bronchial scraping pleural effusion . Patients grant write informed consent . Patients must fulfill inclusion criterion previously mention follow one order enrol study ( visit 1 ) followup progression 9 month begin treatment elapse : Inclusion Criteria patients´ followup Patients document positive mutation epidermal growth factor receptor ( EGFR ) ( M+ ) . Combined histology nonsmall cell small cell lung cancer .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Non-small cell lung cancer ( NSCLC )</keyword>
	<keyword>Epidermal growth factor receptor ( EGFR ) positive mutation</keyword>
</DOC>